CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
standard dose of Cap alone in patients with advanced or metastatic breast cancer. The goal of the study is to assess the efficacy a ...
Phase 2
Tampa, Florida, United States and 12 other locations
A Phase 1, open-label, dose-escalation clinical trial of MBQ-167 in participants with advanced Breast Cancer for whom Standard of C...
Phase 1
Sarasota, Florida, United States and 3 other locations
The purpose of this study is to test the safety and tolerability of PMD-026 in patients with metastatic breast cancer. PMD-026 is a ...
Phase 1, Phase 2
Tampa, Florida, United States and 10 other locations
Assessment of the safety and efficacy of HLD-0117 as monotherapy in patients with estrogen receptor positive (ER+) metastatic breast cancer...
Phase 1
Sarasota, Florida, United States and 2 other locations
as a possible adjuvant treatment for Stage II or III Triple Negative Breast Cancer. This research study is studying the safety, tol...
Phase 1
Tampa, Florida, United States and 4 other locations
growth factor receptor-2 negative (HER2-) advanced/metastatic breast cancer who received no prior cyclin-dependent kinase targeting...
Phase 2
Clearwater, Florida, United States and 33 other locations
A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...
Phase 1
Sarasota, Florida, United States and 16 other locations
Cell (DC1) study vaccine given in combination with pepinemab added to standard of care therapy, trastuzumab to help people with HER2 positive breast...
Phase 1
Tampa, Florida, United States
DESTINY-Breast07 will investigate the safety, tolerability, and anti-tumour activity of trastuzumab deruxtecan (T-DXd) in combination with o ...
Phase 1, Phase 2
St. Petersburg, Florida, United States and 71 other locations
to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...
Phase 3
Clearwater, Florida, United States and 107 other locations
Clinical trials
Research sites
Resources
Legal